BioCardia Inc.

NASDAQ: BCDA
Share price (3/28/25): $2.80
Market cap (3/28/25): $13.1 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement with pricing info

Prospectus supplement with pricing info

Addition of securities to prior initial registration

Ownership Filter

Stertzer Simon H

Stertzer Simon H

Satterfield Thomas a Jr

News Filter

Reports 2024 Business Highlights and Financial Results

Announces Japanese Patent for Helix™ Biotherapeutic Delivery System

Announces Primary Outcome Measures Data Freeze in CardiAMP Heart Failure Trial for Presentation at the American College of Cardiology 2025 Scientific Sessions

Reports Completion of Low Dose Cohort Enrollment for CardiALLO Phase I/II Clinical Trial of BCDA-03 Allogeneic Mesenchymal Stem Cells to Treat Ischemic Heart Failure of Reduced Ejection Fraction

Announces Late Breaking Clinical Trial Presentation on CardiAMP Heart Failure Trial at the American College of Cardiology 2025 Scientific Sessions

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness